Altimmune, Inc.
ALT
$4.06
-$0.02-0.37%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.13% | 15.55% | -1.47% | 7.28% | -1.01% |
| Total Depreciation and Amortization | 3.45% | -12.12% | -10.81% | -39.34% | -42.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -24.59% | 37.06% | 15.86% | -37.04% | 23.93% |
| Change in Net Operating Assets | 134.38% | -124.68% | 138.52% | -302.69% | -39.94% |
| Cash from Operations | -14.90% | 7.80% | 32.65% | -49.76% | -10.70% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2,082.30% | -137.42% | 1,036.95% | 132.44% | 90.65% |
| Cash from Investing | 2,082.10% | -137.42% | 1,036.95% | 132.44% | 90.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8.32% | 246.21% | 3,635.93% | 36.36% | -41.59% |
| Repurchase of Common Stock | 99.12% | -33,800.00% | 50.00% | 98.36% | 59.33% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -361.60% | -- | -- | -- | -- |
| Cash from Financing | 53.12% | 238.31% | 3,691.35% | 678.26% | 82.38% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,000.35% | 123.37% | 121.25% | -17.41% | 61.08% |